Key business areas
Focus has three key areas to its business.
The development of niche medicines, the
management of a portfolio of branded and
generic medicines and the acquisition or
in-licensing of such products.
News and press
Focus successful in UK litigation against Novartis concerning Voleze® Rivastigmine Transdermal Patches
Focus takes a market led approach to product selection. It identifies niche prescription-only products which fit its criterion, and then develops a return model based on potential sales… Go to section
This is generated by utilising Focus to manage the sales of their products through its sales channels. Focus manages a range of niche Brand and Generic Pharmaceuticals for other companies… Go to section
Product Acquisition Focus prefers to acquire niche prescription-only medicines…
Go to section